ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2470

Low Serum Adiponectin Levels Were Associated with Radiographic Progression of Hand Osteoarthritis in a 6-year Follow-up of the Dong-gu Study

Sung-Eun Choi1, Hyemin Jeong1, Dong-Jin Park1, Ji-Hyoun Kang2, Min-Ho Shin3 and Shin-Seok Lee1, 1Chonnam National University Medical School & Hospital, Gwangju, South Korea, 2Chonnam National University Hospital, Gwangju, South Korea, 3Chonnam National University Medical School, Gwangju, South Korea

Meeting: ACR Convergence 2023

Keywords: Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Osteoarthritis II: Novel Insights from Observational Studies

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: The association between serum adiponectin levels and hand osteoarthritis (OA) has been studied cross-sectionally, but longitudinal studies on the radiographic progression of hand OA are lacking. Thus, we investigated the relationship between serum adiponectin levels and radiographic features of hand OA in a prospective longitudinal cohort.

Methods: A total of 1,356 subjects were enrolled from the Dong-gu study. Baseline serum adiponectin levels were measured by enzyme linked immunosorbent assay, and hand joint radiographs were assessed using a semi-quantitative grading system at the first visit and 6 years later. Multiple linear regression analysis was used to investigate the association between serum adiponectin levels and radiologic changes in hand OA.

Results: Total hand joint scores increased from 16.5 ± 5.74 at baseline to 19.4 ± 8.11 at year 6 (p < 0.001). The baseline adiponectin levels were negatively associated with the changes in total hand joint score (p = 0.019), subchondral cyst score (p = 0.006), and malalignment score (p = 0.026) after adjusting for age, gender, body mass index, smoking, alcohol consumption, education, physical activity, hypertension, diabetes mellitus, dyslipidemia, chronic pulmonary disease, chronic liver disease, cardiovascular disease, cerebrovascular disease, and malignancy. When serum adiponectin levels above and below the median were compared with the total score for hand OA based on the median radiographic scores, subjects with serum adiponectin levels below the median exhibited radiographic progression in hand joints after adjustment (odds ratio = 0.618, 95% confidence interval: 0.477–0.801, p < 0.001).

Conclusion: In this longitudinal population-based study, decreased serum adiponectin levels were associated with progression of radiographic hand OA.


Disclosures: S. Choi: None; H. Jeong: None; D. Park: None; J. Kang: None; M. Shin: None; S. Lee: None.

To cite this abstract in AMA style:

Choi S, Jeong H, Park D, Kang J, Shin M, Lee S. Low Serum Adiponectin Levels Were Associated with Radiographic Progression of Hand Osteoarthritis in a 6-year Follow-up of the Dong-gu Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/low-serum-adiponectin-levels-were-associated-with-radiographic-progression-of-hand-osteoarthritis-in-a-6-year-follow-up-of-the-dong-gu-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-serum-adiponectin-levels-were-associated-with-radiographic-progression-of-hand-osteoarthritis-in-a-6-year-follow-up-of-the-dong-gu-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology